BRF Invested in Israeli Startup Aleph Farms to Have Great Innovation and Technology to Meet New Consumer Habits
Yesterday, BRF announced that it is the only Brazilian food company participating in the second international investment round of Aleph Farms, an Israeli startup and one of the leading global players in cultivated meat, developed from non-genetically modified bovine cells. BRF made investments of US$ 2.5 million in this operation, joining other corporations and individuals, since the goal is to develop protein in the lab from animal cells. Check out: BRF will invest R$ 670 million in two factories in Mato Grosso, aiming to expand production capacity
- Amid Water Crisis, Solar and Wind Energy Generation Break Records in the Northeast
- Australian Mining Company Invests US$ 6 Billion to Build Green Hydrogen Plant in Ceará
- GM Plans to Extract Lithium Independently for Use in Its Electric Car Batteries
- Repsol Sinopec Brasil Invests in Using Robots for FPSO Tank Maintenance
- South Korean Automaker Hyundai Completely Halts Vehicle Production at Piracicaba Plant in São Paulo
New Objectives of BRF in Investing in the Israeli Startup
With this move, BRF states that it is taking another step in its plan to meet the growing consumer demand for new and alternative sources of protein, bringing innovative technologies to Brazil. Unlike other partnerships and acquisitions, this is the first time the company has made a venture capital transaction.
Lorival Luz, Global CEO of BRF, states that “We understand our role in this transformation of the food industry, and that is why we are investing in Aleph Farms, a company that shares our goal of providing quality food, made with disruptive technology, to all people. Innovation is in BRF’s DNA, and we know how to reinvent ourselves to bring solutions to feed the future.”
-
The prospector who heard about the advance of soy in Maranhão and opened a grocery store in Balsas in 1986 transformed that small store into Grupo Mateus, the third largest supermarket in Brazil, with revenues of R$ 43.5 billion and 490 units.
-
Fiserv, the world’s largest payment processor, has just inaugurated its first factory outside Asia in Brazil. The unit in Betim (MG) will produce 100,000 Clover payment terminals per year and is part of a US$100 million investment that includes technology and expansion until 2027.
-
Fiserv, the world’s largest payment processor, has just opened its first factory outside Asia in Brazil. The unit in Betim (MG) will produce 100,000 Clover payment terminals per year and is part of a US$100 million investment that includes technology and expansion until 2027.
-
Pix could become a headache between Brazil and the US, and the Lula government will go to the White House to explain the system before pressure mounts.
BRF Growth Strategy
In a statement issued by BRF, the investments are also part of an important milestone for BRF towards the growth strategy presented in Vision 2030, a strategic plan that will lead the company to achieve revenue exceeding R$ 100 billion in the next decade, establishing itself as one of the leaders in the global food sector.
In March of this year, BRF had already announced a partnership with Aleph Farms when it became the first Brazilian company to advance its portfolio with products made from cultivated animal cells. The novelty arose with the development of biotechnology in food production, bringing benefits to the production chain and advantages for the environment, in addition to catering to diverse consumer profiles.
Marcel Sacco, Vice President of New Business at BRF, states that it is a rapidly expanding market, and they aim to lead this transformation in how proteins are consumed. According to him, they believe that this investment and the strategic partnership with Aleph Farms represent the future of the relationship with the food industry and help to empower startups that are at the forefront of the transformation.
Details About “Cultivated Meat”
All meat is composed of cells, even the smallest living beings in nature. The production of cultivated meat begins with the collection of high-quality cells from animals, but without slaughter. The cells are cultivated outside the animal’s body with the supply of nutrients and a suitable environment for their development. The automated process and sterile environment eliminate the need for antibiotics and significantly reduce the risk of pathogens or contaminants. This entire process takes a fraction of the time required to cultivate conventional meat with a fraction of the resources it demands.

Be the first to react!